Perrigo Drops After Saying FDA to Reject Inhaler, Delaying Start

(Bloomberg) -- Perrigo Co. said it expects U.S. regulators will reject its application for what one analyst had a called its must-have asthma inhaler, a generic version of Teva Pharmaceutical Indus...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.